Skip to content

Bedside ultrasound monitoring of optic nerve sheath to guide intracranial hypertension: a randomized controlled trial of precise treatment for patients

Bedside ultrasound monitoring of optic nerve sheath to guide intracranial hypertension: a randomized controlled trial of precise treatment for patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018906
Enrollment
Unknown
Registered
2018-10-16
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial hypertension

Interventions

Group 1:Ultrasonographic monitoring of optic nerve sheath diameter
Group 2:no

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. aged at least 18 years old; men and women; 2. diagnosis or clinical diagnosis of stroke; 3. one of the high risk factors for intracranial hypertension; Imaging confirmed that the lesion was larger than 70cm3 or had cerebral edema; After onset, blood pressure increased significantly compared with baseline. Delta SBP > 40mmhg; Multiple organ dysfunction: Acute changes in SOFA score (> 2), or (> 2) in SOFA score (baseline SOFA score was 0 in patients with unknown organ dysfunction); The presence of blood glucose was significantly elevated or too low (> 11.1mmol/L or 2; 4. informed consent of patients or family members.

Exclusion criteria

Exclusion criteria: 1. In recent months (6 months), chemotherapy drugs were used; 2. There is a history of hematologic malignancies and autoimmune diseases; 3. There are hematopoietic stem cell transplantation, liver, kidney, lung, pancreas and other solid organ transplant history; 4. The end stage of renal failure (GFR 707 mol/L); 5. The expected survival time is <24 hours; 6. Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
28 day mortality;

Countries

China

Contacts

Public ContactHui Xie

Shanghai General Hospital

zhaolina8680@126.com+86 13761814287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026